Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
Are serious heart problems inevitable for people with HIV? A conversation with cardiologist Priscilla Hsue

Priscilla Hsue, MD, FACC, a cardiologist at Zuckerberg San Francisco General Hospital spoke about heart health and inflammation, and why cardiovascular conditions are becoming a growing concern for people growing older with HIV.

Published
16 March 2017
From
BETA blog
Studies look at brain and cognitive changes in people with HIV as they age

People with HIV often show persistent signs of cognitive impairment and abnormalities in brain structure despite suppressive antiretroviral therapy (ART), but they do not appear to experience

Published
14 March 2017
By
Liz Highleyman
Minority Within A Minority: Women Ageing With HIV

My research is a three year project, exploring what it is like to be an older women with HIV, how the social and physical experiences of ageing are affected by HIV, and what support exists or is needed to enable older women living with HIV to age well.

Published
09 March 2017
From
Huffington Post
High prevalence and incidence of hypertension among rural Africans living with HIV

The research conducted by Swiss TPH is among the first longitudinal studies looking at the development of hypertension among people living with HIV in sub-Saharan Africa. In a cohort of 955 HIV-infected people, 111 (11.6%) were hypertensive.

Published
09 March 2017
From
EurekAlert (press release)
New antibody therapy “profoundly” successful at reducing inflammation from HIV

In a very small study of people living with HIV, a one-time antibody treatment significantly reduced the type of inflammation that can lead to heart attacks and other cardiovascular problems.

Published
09 March 2017
From
BETA blog
D:A:D study – long-term use of darunavir/ritonavir modestly increases the risk of cardiovascular disease

Long-term use of the protease inhibitor darunavir/ritonavir modestly increases the risk of cardiovascular disease, according to data from the ongoing D:A:D study presented to the recent Conference on

Published
08 March 2017
By
Michael Carter
Clinical Commissioning Policy: Tenofovir Alafenamide for treatment of HIV 1 in adults and adolescents

TAF containing products can be made available to patients who have defined renal or bone problems or who have medical reasons why they cannot take other HIV drugs.

Published
06 March 2017
From
NHS England
Integrase inhibitors may increase risk of IRIS in late presenters for HIV treatment

HIV integrase inhibitors such as dolutegravir and raltegravir may increase the risk of immune reconstitution inflammatory syndrome (IRIS), studies from the Netherlands and France presented

Published
01 March 2017
By
Keith Alcorn
Well-Treated HIV Is Still Associated With Vascular Abnormalities in the Brain

More research is needed into how the virus may affect cerebral small vessel disease, a leading cause of cognitive decline.

Published
28 February 2017
From
Poz
Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have

Published
27 February 2017
By
Liz Highleyman
← First12345...152Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.